Cadherin-6 in Focus: Existing Antibodies, Emerging Applications

Conference Coverage
24/10/2025 2 min

Listen "Cadherin-6 in Focus: Existing Antibodies, Emerging Applications "

Descargar episodio Ver en sitio original

Episode Synopsis



Guest: Gary S. Firestein, MD



While cadherin-6 may not yet shift clinical practice in rheumatoid arthritis, its role as a surface-expressed, actionable target opens the door to rapid therapeutic development—particularly with existing antibodies already in clinical trials for urologic cancers. Dr. Gary Firestein discusses the potential for cadherin-6 to become a useful target across multiple diseases. Dr. Firestein is a Distinguished Professor of Medicine and the Senior Associate Vice Chancellor for Health Sciences at UC San Diego.

More episodes of the podcast Conference Coverage

Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer 22/12/2025
From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer 22/12/2025
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH 16/12/2025
Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD 10/12/2025
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care 10/12/2025
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer 09/12/2025
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases 09/12/2025
CLL17 Trial Insights: Fixed-Duration vs Continuous Therapy in Frontline CLL 08/12/2025
Rethinking Hormones: Testosterone and Estrogen in Women’s Heart Health 21/11/2025
Targeting Vascular KCNQ5 Channels: A Promising Strategy for Blood Pressure Control 21/11/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA